A commentary from Prof. Lehrach in the Personalized Medicine magazine.
The article is in the Special Focus Issue: European Science Foundation: Personalized Medicine Forward Look and freely accessible here.
About the magazine (from the homepage of Personalized Medicine):
Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis.
The contents of the current issue can be found here.